Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B study

Journal of Clinical Oncology

Volumn 19, Issue 9, 2001, Pages 2482-2492

  Mrozek K ^a   Prior, T W ^a   Edwards, C ^a   Marcucci, G ^a   Carroll, A J ^a   Snyder, P J ^a   Koduru, P R K ^a   Theil, K S ^a   Pettenati, M J ^a   Archer, K J ^a   Caligiuri, M A ^a   Vardiman, J W ^a   Kolitz, J E ^a   Larson, R A ^a   Bloomfield, C D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CHROMOSOME 16; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HUMAN; KARYOTYPE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035339877     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.9.2482     Document Type: Article

References (52)

1. Oncogenic transcription factors in the human acute leukemias
2. Clinical significance of cytogenetics in acute myeloid leukemia
3. Long-term survival of patients with acute myeloid leukemia: A third follow-up of the Fourth International Workshop on Chromosomes in Leukemia
4. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
5. Acute myeloid leukemia
6. Molecular biology of leukemias
7. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype
8. Is trisomy 22 in acute myeloid leukemia a primary abnormality or only a secondary change associated with inversion 16?
9. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission
10. Core-binding factor (CBF) and MLL-associated primary acute myeloid leukemia: Biology and clinical implications
11. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the t(8;21)(q22;q22) translocation
12. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia
13. Heterogeneity in CBF-Beta/MYH11 fusion messages encoded by the inv(16) (p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia
14. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts
15. Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: Correlation with cytogenetics, morphology and immunophenotype
16. Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials
17. Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML
18. Detection of karyotypic aberrations in acute myeloblastic leukaemia: A prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML
19. Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia
20. Detection of chromosome 16 CBF-beta/MYH11 fusion transcript in myelomonocytic leukaemias
21. Frequency of CBF-beta/MYH11 fusion transcripts in patients entered into the UK MRC AML trials
22. Underestimation of inversion (16) in acute myeloid leukaemia using standard cytogenetics as compared with polymerase chain reaction: Results of a prospective investigation
23. High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study
24. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group
25. Trisomy 13: A new recurring chromosome abnormality in acute leukemia
26. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation
27. Fusion between transcription factor CBF-beta/PEBP2-Beta and a myosin heavy chain in acute myeloid leukemia
28. A novel method for real time quantitative RT-PCR
29. Real time quantitative PCR
30. Detection of minimal residual disease in patients with AML/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay
31. Multicolor spectral karyotyping of human chromosomes
32. Screening
33. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia
34. Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: A multicenter study of 51 patients
35. Translocation (8;21) and its variants in acute nonlymphocytic leukemia. The relative importance of chromosomes 8 and 21 to the genesis of the disease
36. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(pl 1;q22) and identification of a novel transcript
37. Simple variant t(8;21) acute myeloid leukemias harbor insertions of the AML1 or ETO genes
38. Translocation (8;12;21)(q22.1;q24.1;q22.1): A new masked type of t(8;21)(q22;q22) in a patient with acute myeloid leukemia
39. Fluorescence in situ hybridization analysis of masked (8;21)(q22;q22) translocations
40. Acute myelogenous leukemia with ins(21;8) expressing AML-1-MTG8 fusion script
41. Detection of translocation 8;21 on interphase cells from acute myelocytic leukemia by fluorescence in situ hybridization and its clinical application
42. Long-term survival in acute myelogenous leukemia: A second follow-up of the Fourth International Workshop on Chromosomes in Leukemia
43. Very low level of major BCR-ABL expression in blood of some healthy individuals
44. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation
45. Identification of false-positive CBF-beta/MYH11 RT-PCR results
46. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification
47. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia
48. FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia
49. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis